Fidelity Select Portfolios - Medical Technology and Devices Portfolio Current Cash

The latest current cash for FSMEX is $200K as of September 2023. That compares with $610K in the prior-year period — down 67.7% year over year. Investors often review this figure alongside Fidelity Select Portfolios - Medical Technology and Devices Portfolio's historical trend and sector peers before judging valuation or financial health.

Over the past year, FSMEX's current cash moved from $610K to $200K — a 67.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fidelity Select Portfolios - Medical Technology and Devices Portfolio's operating scale or balance-sheet position.

A current cash figure of $200K for FSMEX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FSMEX's current cash ($200K), review year-over-year change from $610K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.